Scilex Ownership | Who Owns Scilex?
Scilex Ownership Summary
Scilex is owned by 10.98% institutional investors, 1.55% insiders, and 87.48% retail investors. Norges bank is the largest institutional shareholder, holding 0.12% of SCLX shares. SPDR® S&P Biotech ETF is the top mutual fund, with 3.24% of its assets in Scilex shares.
SCLX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Scilex | 10.98% | 1.55% | 87.48% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Drug Manufacturers - General Stocks | 37.59% | 1.26% | 61.15% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Norges bank | 13.64K | 0.12% | $80.36M |
| Versant capital management | 761.00 | 0.01% | $4.48K |
| Activest wealth management | 302.00 | 0.00% | $1.78K |
| Gamma investing | 46.00 | 0.00% | $271.00 |
| Larson financial group | 42.00 | 0.00% | $247.00 |
| Northwestern mutual wealth management | 31.00 | 0.00% | $183.00K |
| Operose advisors | 20.00 | 0.00% | $118.00 |
| Golden state wealth management | 20.00 | 0.00% | $118.00 |
| New england capital financial advisors | 23.00 | 0.00% | $136.00 |
| Harbour investments | 8.00 | 0.00% | $47.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant capital management | 761.00 | 0.00% | $4.48K |
| Activest wealth management | 302.00 | 0.00% | $1.78K |
| New england capital financial advisors | 23.00 | 0.00% | $136.00 |
| Geode capital management | - | - | - |
| Parallel advisors | 3.00 | - | $18.00 |
| Perigon wealth management | - | - | - |
| Prudential financial | - | - | - |
| Golden state wealth management | 20.00 | - | $118.00 |
| Baillie gifford | - | - | - |
| Renaissance | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 13.64K | - | 13.64K |
| Versant capital management | 761.00 | 0.00% | 761.00 |
| Activest wealth management | 302.00 | 0.00% | 302.00 |
| Gamma investing | 46.00 | - | 46.00 |
| Larson financial group | 42.00 | - | 42.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -13.79M |
| State street | - | - | -7.59M |
| Blackrock funding, inc. /de | - | - | -6.74M |
| Vanguard group | - | - | -5.90M |
| Geode capital management | - | - | -1.61M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 13.64K | - | 13.64K | $80.36M |
| Versant capital management | 761.00 | 0.00% | 761.00 | $4.48K |
| Activest wealth management | 302.00 | 0.00% | 302.00 | $1.78K |
| Gamma investing | 46.00 | - | 46.00 | $271.00 |
| Larson financial group | 42.00 | - | 42.00 | $247.00 |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -1.00 |
| Pnc financial services group | -9.00 |
| Plante moran financial advisors | -14.00 |
| Trust co of vermont | -29.00 |
| Stephens consulting | -245.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 78 | -20.41% | 44,442,233 | 6.91% | 10 | 1.02% | 24 | -38.46% | 16 | 33.33% |
| Dec 31, 2024 | 99 | 6.45% | 49,076,082 | 45.69% | 38 | 5.49% | 40 | 25.00% | 12 | -20.00% |
| Sep 30, 2024 | 93 | 2.20% | 33,684,178 | -15.43% | 26 | 2.42% | 32 | 18.52% | 15 | -16.67% |
| Jun 30, 2024 | 91 | -9.90% | 39,830,277 | 41.48% | 33 | 4.39% | 27 | -42.55% | 18 | 80.00% |
| Mar 31, 2024 | 101 | 9.78% | 28,151,703 | 8.49% | 27 | 6.93% | 47 | 38.24% | 10 | -16.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| SPDR® S&P Biotech ETF | 169.67K | 3.24% | - |
| Vanguard Total Stock Mkt Idx Inv | 162.40K | 2.88% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 84.66K | 1.50% | - |
| Vanguard Balanced Index Inv | 44.34K | 0.79% | 41.49K |
| iShares Russell 2000 ETF | 40.87K | 0.74% | - |
| Fidelity Extended Market Index | 24.61K | 0.44% | -65.00 |
| Direxion Daily S&P Biotech Bull 3X ETF | 17.72K | 0.32% | - |
| iShares Russell 2000 Value ETF | 576.36K | 0.31% | - |
| JPM Thematics Genetic Thrps C2 Acc USD | 397.32K | 0.30% | - |
| BlackRock Extended Equity Market K | 375.77K | 0.28% | -160.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 18, 2024 | SHAH JAISIM | See Remarks | Buy | $13.80K |
| Oct 31, 2024 | Ji Henry | Executive Chairperson | Buy | $8.35K |
| Oct 29, 2024 | SHAH JAISIM | See Remarks | Buy | $31.67K |
| Oct 18, 2024 | Followwill Dorman | - | Buy | $990.00 |
| Oct 18, 2024 | Chun Jay | - | Buy | $4.75K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | 10 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | 5 | - |
| 2024 Q1 | - | - |
SCLX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools